IQE PLC IQE: Options Issue & Director/PDMR Shareholding

RNS Number : 8641E

IQE PLC

29 February 2024

 

IQE plc

 

 

Cardiff, UK

29 February 2024

 

 

 

Issue of Options and Director/PDMR Shareholding

 

 

IQE plc (AIM:  IQE, "IQE" or the "Group"), the leading global supplier of compound semiconductor wafer products and advanced material solutions, confirms that further to the announcement of 16 January 2024 regarding the appointment of Jutta Meier as Chief Financial Officer of the Company, a total of 995,521 options ("Options") over ordinary shares of 1 pence each in the Company ("Ordinary Shares") have been awarded to Ms Meier as part of a New Starter Award.

The number of options awarded have been calculated based on the average volume weighted IQE plc share price on the three trading days preceding 22 January 2024. The Options will vest in two equal tranches over two years subject to continued employment.

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")
a)	Name	Ms Jutta Meier
2.	Reason for the notification
a)	Position / status	Chief Financial Officer
b)	Initial notification / amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	IQE plc
b)	Legal Entity Identifier	213800Y33WHD3ESJJP16
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Ordinary shares of 1 pence each in the Company GB0009619924
b)	Nature of the transaction	Award of options
c)	Price(s) and volume(s)	Price Volume 20.09p 995,521
d)	Aggregated information ·       Aggregated volume ·       Aggregated price	See above
e)	Date of the transaction(s)	28 February 2024
f)	Place of the transaction	Off-market

 

Contacts:

 

IQE plc

[phone]

Americo Lemos

Jutta Meier

Amy Barlow

           

Peel Hunt (Nomad and Joint Broker)

[phone]

Paul Gillam

Tom Ballard

Kate Bannatyne

Adam Telling

           

Deutsche Numis (Joint Broker)

[phone]

Simon Willis

Hugo Rubinstein

Iqra Amin

 

Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822

Andy Rivett-Carnac: [phone]

Chloe Francklin: [phone]

 

ABOUT IQE

http://iqep.com

 

 

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

 

·    Smart Connected Devices

·    Communications Infrastructure

·    Automotive and Industrial

·    Aerospace and Security

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across eight manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHFLFSTFIITFIS